Topoisomerase IIα gene amplification and response to anthracycline-containing adjuvant chemotherapy in breast cancer

被引：18
作者：
Buzdar, Aman J. [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 16期
关键词：
D O I：
10.1200/JCO.2006.05.9113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2409 / 2411
页数：3
相关论文
共 29 条
[1]  
Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
[2]  
[Anonymous], 1988, NEW ENGL J MED, V319, P1681
[3]   Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIα for anthracycline chemotherapy in locally advanced breast cancer [J].
Arpino, G ;
Ciocca, DR ;
Weiss, H ;
Allred, DC ;
Daguerre, P ;
Vargas-Roig, L ;
Leuzzi, M ;
Gago, F ;
Elledge, R ;
Mohsin, SK .
BREAST CANCER RESEARCH AND TREATMENT, 2005, 92 (01) :69-75
[4]   Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: a review of chemotherapy [J].
Barrett-Lee, PJ .
ENDOCRINE-RELATED CANCER, 2005, 12 :S125-S133
[5]   HER-2/neu and topoisomerase IIα gene amplification and protein expression in invasive breast carcinomas -: Chromogenic in situ hybridization and immunohistochemical analyses [J].
Bhargava, R ;
Lal, P ;
Chen, BY .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (06) :889-895
[6]  
BUZDAR AU, 1985, CANCER, V55, P2761, DOI 10.1002/1097-0142(19850615)55:12<2761::AID-CNCR2820551206>3.0.CO
[7]  
2-P
[8]   ADJUVANT THERAPY WITH ESCALATING DOSES OF DOXORUBICIN AND CYCLOPHOSPHAMIDE WITH OR WITHOUT LEUKOCYTE ALPHA-INTERFERON FOR STAGE-II OR STAGE-III BREAST-CANCER [J].
BUZDAR, AU ;
HORTOBAGYI, GN ;
KAU, SWC ;
SMITH, TL ;
FRASCHINI, G ;
HOLMES, FA ;
GUTTERMAN, JU ;
HUG, VM ;
SINGLETARY, SE ;
AMES, FC ;
MCNEESE, MD .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (10) :1540-1546
[9]   DNA topoisomerases: Structure, function, and mechanism [J].
Champoux, JJ .
ANNUAL REVIEW OF BIOCHEMISTRY, 2001, 70 :369-413
[10]  
Coon JS, 2002, CLIN CANCER RES, V8, P1061
123